These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 17217332)
1. New therapeutic approaches for multiple sclerosis. De Jager PL; Hafler DA Annu Rev Med; 2007; 58():417-32. PubMed ID: 17217332 [TBL] [Abstract][Full Text] [Related]
2. Toward the development of rational therapies in multiple sclerosis: what is on the horizon? Hemmer B; Hartung HP Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020 [TBL] [Abstract][Full Text] [Related]
3. Immunomodulatory drug treatment in multiple sclerosis. Aharoni R Expert Rev Neurother; 2010 Sep; 10(9):1423-36. PubMed ID: 20819013 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis. Aktas O; Kieseier B; Hartung HP Trends Neurosci; 2010 Mar; 33(3):140-52. PubMed ID: 20045200 [TBL] [Abstract][Full Text] [Related]
5. [Current state of research on multiple sclerosis]. Lubina-Dabrowska N; Stepień A; Chalimoniuk M Pol Merkur Lekarski; 2013 Mar; 34(201):135-9. PubMed ID: 23700821 [TBL] [Abstract][Full Text] [Related]
6. Linkage between immunomodulation, neuroprotection and neurogenesis. Aharoni R; Arnon R Drug News Perspect; 2009; 22(6):301-12. PubMed ID: 19771319 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic decision making in a new drug era in multiple sclerosis. Keegan BM Semin Neurol; 2013 Feb; 33(1):5-12. PubMed ID: 23709208 [TBL] [Abstract][Full Text] [Related]
8. Mode of action and clinical studies with fumarates in multiple sclerosis. Salmen A; Gold R Exp Neurol; 2014 Dec; 262 Pt A():52-6. PubMed ID: 24568735 [TBL] [Abstract][Full Text] [Related]
9. [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis]. Kleinschnitz C; Meuth SG; Kieseier BC; Wiendl H Nervenarzt; 2007 Aug; 78(8):883-911. PubMed ID: 17551708 [TBL] [Abstract][Full Text] [Related]
10. Future research directions in multiple sclerosis therapies. Greenberg BM; Calabresi PA Semin Neurol; 2008 Feb; 28(1):121-7. PubMed ID: 18256992 [TBL] [Abstract][Full Text] [Related]
11. Disease-modifying treatments for progressive multiple sclerosis. Comi G Mult Scler; 2013 Oct; 19(11):1428-36. PubMed ID: 24062415 [TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis: new insights in pathogenesis and novel therapeutics. Ontaneda D; Hyland M; Cohen JA Annu Rev Med; 2012; 63():389-404. PubMed ID: 21888515 [TBL] [Abstract][Full Text] [Related]